Recent studies showed patients with low or no MHC expression tumors who respond to anti-PD-1 therapy, emphasizing that cells other than cytotoxic T cells also express PD-1, and could be responsible for anti-tumor immunity [24,25]. The gene discussed is HLA-C; the disease is neoplasm.